Evidence map›Paper›PMID 30604928›Full record

ArticleInternational wound journal2019

Can systemically administered antibiotics be detected in wound tissues and surfaces under negative pressure wound therapy?

Elias Polykandriotis, Raymund E Horch, Matthias Jost, Andreas Arkudas, Frieder Kees, Marweh Schmitz

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in International wound journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06506032 (Clinical Effect and Wound Penetration of Vancomycin in Open-heart Surgery Patients Receiving Negative Pressure Wound Therapy for Deep Sternal Wound Infection), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06506032 completednot on this mapstarted 2021, after this paper: background citation

Clinical Effect and Wound Penetration of Vancomycin in Open-heart Surgery Patients Receiving Negative Pressure Wound Therapy for Deep Sternal Wound Infection

TypeobservationalSponsorUniversity Hospital OstravaRan2021 to 2023Enrolled10ConditionsPost-Sternotomy Deep Sternal Wound InfectionArmsIntravenous Vancomycin administration, Standard postoperative therapy
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Elias PolykandriotisDepartment of Plastic, Hand and Microsurgery, Sana Klinikum Hof, Hof, Germany.ORCID https://orcid.org/0000-0002-8152-6420
Raymund E HorchDepartment of Plastic and Hand Surgery, University of Erlangen Medical Center, Erlangen, Germany.
Matthias JostDepartment of Internal Medicine 6, Gastrenterology, Endocrinology, Klinikum Nuernberg, Nurnberg, Germany.
Andreas ArkudasDepartment of Plastic and Hand Surgery, University of Erlangen Medical Center, Erlangen, Germany.
Frieder KeesInstitute for Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany.
Marweh SchmitzDepartment of Plastic and Hand Surgery, University of Erlangen Medical Center, Erlangen, Germany.
Universitätsklinikum Erlangen · DENuremberg Hospital · DEUniversity of Regensburg · DE

Funding

Bayer Healthcare AG
6 · The paper itself

Abstract

In this study, we evaluated a new aspect of negative pressure wound therapy (NPWT) as an analytical tool for pharmacokinetic studies. Twenty-one patients with soft tissue defects scheduled to receive NPWT were included in this study. Concomitant to NPWT, all patients received intravenous moxifloxacin (MX). At different time intervals, blood plasma levels of MX were sampled and compared with synchronous concentrations of MX in the exudate obtained from the NPWT drainage system. Serial measurements were performed upon initiation of the therapy as well as in the steady state (after 5 days). At steady state, wound tissue was obtained intraoperatively. High-performance liquid-chromatography (HPLC) was used for analysis. At 1 hour post-administration, the exudate/plasma levels (mg/L) were 1.92/3.07; at 12 hours, 0.80/1.14; at 24 hours, 0.26/0.43; and at 120 hours (steady state), 0.42/0.47. There was a correlation between exudate and plasma levels reaching approximately 0.75. Until now, methods for pharmacokinetic studies concerning interstitial fluid are difficult to apply in the clinical context. The presented method showed limitations, but we believe that, after methodological improvements, measurements of substances in the interstitial fluid by means of NPWT are feasible.

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsExudates and TransudatesFemaleGermanyHumansMaleMiddle AgedMoxifloxacinNegative-Pressure Wound TherapyWound HealingWounds and InjuriesAnti-Bacterial AgentsMoxifloxacininterstitial fluidmoxifloxacinnegative pressure wound therapy (NPWT)pharmacokineticswound infection

Identifiers

PMID30604928
PMCPMC7948631
OpenAlexW2906843194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.